1-{2-[(dimethylamino)methyl]-4-methoxyphenyl}ethan-1-one
CAS: 77973-25-2
Rif. 3D-CDA97325
1g | Fuori produzione | ||
5g | Fuori produzione | ||
100mg | Fuori produzione | ||
250mg | Fuori produzione | ||
500mg | Fuori produzione | ||
2500mg | Fuori produzione |
Informazioni sul prodotto
- 1-(2-Dimethylaminomethyl-4-methoxy-
- Phenyl)-Ethanone
- 1-{2-[(Dimethylamino)methyl]-4-methoxyphenyl}ethanone
- Ethanone, 1-[2-[(Dimethylamino)Methyl]-4-Methoxyphenyl]-
Fluphenazine is a typical antipsychotic. It is used to treat schizophrenia and other psychoses, including those associated with Alzheimer's disease. Fluphenazine is a phenothiazine derivative that has shown to be effective in treating the symptoms of dementia and alzheimer's disease. This drug also has anti-depressant effects and is used to prevent relapse in people who have been treated for depression. Fluphenazine can cause a range of side effects, such as dry mouth, dizziness, drowsiness, blurred vision, constipation and urinary retention.